Genzyme Will Look To Differentiate Renvela With Improved Dosing
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm will also try to expand patient population for Renagel follow-on to predialysis setting, Renal Division head tells “The Pink Sheet” DAILY.
You may also be interested in...
Genzyme’s Renvela Approved For Kidney Disease Patients On Dialysis
Filing for predialysis indication is on track for first half of 2008 after “positive” outcome of FDA Cardio-Renal Advisory Committee meeting, Genzyme Renal President Butler tells “The Pink Sheet” DAILY.
Genzyme’s Renvela Approved For Kidney Disease Patients On Dialysis
Filing for predialysis indication is on track for first half of 2008 after “positive” outcome of FDA Cardio-Renal Advisory Committee meeting, Genzyme Renal President Butler tells “The Pink Sheet” DAILY.
FDA Cardio-Renal Drugs Panel Will Discuss Pre-Dialysis Use For Phosphate Binders
The Oct. 16-17 meeting will also discuss data requirements, study designs for pediatric indication for Pfizer’s Revatio in PAH.